"10.1371_journal.pone.0053668","plos one","2013-01-09T00:00:00Z","Stefan Balabanov; Thomas Wilhelm; Simone Venz; Gunhild Keller; Christian Scharf; Heike Pospisil; Melanie Braig; Christine Barett; Carsten Bokemeyer; Reinhard Walther; Tim H Brümmendorf; Andreas Schuppert","Department of Oncology, Haematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald-Tumor Zentrum (UCCH), University Hospital Eppendorf (UKE), Hamburg, Germany; Division of Hematology, University Hospital Zürich, Zürich, Switzerland; Department of Biochemistry, University Hospital Aachen (UKA) of the Rheinisch.-Westfälische Technische Hochschule Aachen, Aachen, Germany; Department of Medical Biochemistry and Molecular Biology, University of Greifswald, Greifswald, Germany; Interfacultary Institute of Genetics and Functional Genomics, University of Greifswald, Greifswald, Germany; Department of Otorhinolaryngology, Head and Neck Surgery, University of Greifswald, Greifswald, Germany; Bioinformatics, University of Applied Sciences Wildau, Wildau, Germany; Medizinische Klinik IV - Hämatologie und Onkologie, Universitätsklinikum Aachen (UKA) of the Rheinisch.-Westfälische Technische Hochschule Aachen, Aachen, Germany; Aachen Institute for Advanced Study in Computational Engineering Science (AICES), RWTH Aachen University, Aachen, Germany","Conceived and designed the experiments: SB AS THB. Performed the experiments: SB TW SV CS MB C. Barett AS. Analyzed the data: SB SV CS HP AS. Wrote the paper: SB GK MB C. Bokemeyer RW AS THB.","THB received research support from Novartis and Bristol-Meyers Squibb. Furthermore THB participated in clinical trials investigating Imatinib, Nilotinib, Dasatinib and Danusertib in CML patients. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","01","Stefan Balabanov","SB",12,TRUE,3,6,5,4,TRUE,TRUE,TRUE,1,"10",FALSE
